Articles tagged with Infectious Diseases
Researchers at UT San Antonio develop non-toxic biologic to prevent Lyme disease transmission. The treatment targets small mammals and birds, reducing bacterial loads in ticks, and may soon be available for residential use.
A study of 193 countries finds that armed conflict leads to more measles cases, even a year after fighting ends. Socioeconomic decline is the strongest connection between conflict and measles, as it erodes health foundations and population vulnerability.
Researchers developed a pH-triggered nanocomposite that synchronizes the release of therapeutic agents, combating bacterial biofilms and oxidative stress. The platform accelerates healing and promotes tissue repair in infected wounds.
The study found that sepsis continues to be a significant cause of mortality in China, with infections accounting for the majority of deaths. The analysis also revealed age-related differences in sepsis burden, with older adults and males consistently carrying the highest risk.
A new study finds that climate change can impact flu season timing and severity across North, Central, and South America. Weather conditions like temperature and humidity help predict outbreaks, with tropical regions potentially experiencing stronger outbreaks while places with distinct seasons see smaller ones.
Researchers developed a tool to observe complex molecular choreography in real-time, shedding light on how a key protein locates the correct regions of the genome to initiate an adaptive response. The study proposes that transcription produces a 'dynamic RNA hub' that recruits the DNA mutator protein AID.
Researchers at the German Center for Infection Research have developed a promising single-dose malaria treatment called SPAP, which targets the malaria parasite through multiple mechanisms. The four-drug combination therapy has shown significant promise in improving malaria treatment and could be a major advancement in sub-Saharan Africa.
Scientists have identified a unique chimeric RNA called UBA1-CDK16 that plays important roles in women's blood cell development and disease severity. The findings suggest the chimeric RNA may serve as a natural brake to protect women from excessive autoimmune activity.
Hantavirus and Ebola virus disease are two deadly infectious diseases that require rigorous infection and prevention control (IPAC) practices. Both diseases present with similar early symptoms and can be treated effectively with proper precautions.
A global study confirms mosquito nets reduce malaria cases by up to 68%, but highlights regional variations and the need for locally adapted control strategies. The researchers warn that relying on ITNs alone may not be enough, especially in areas with established insecticide resistance.
A deadly hantavirus cluster on a cruise ship has sparked global alarm, but new research highlights the overlooked risk of agricultural and wildlife farming environments. The study calls for a One Health approach to protect agricultural workers worldwide from this preventable occupational risk.
A clinical trial tested four remote monitoring approaches against usual care and found that none outperformed usual care in reducing readmissions. The study highlights the importance of studying real-world care models to optimize outcomes.
Remote monitoring approaches did not increase home time but reduced it for those 65 years and older, supporting tailored care after acute infections. The findings suggest reevaluating remote monitoring to align with patients' needs and desires.
A nationwide survey in Japan found a gradual but steady decline in health-related quality of life among the working-age population over seven years. The study also revealed regional differences in HRQoL across prefectures.
According to new research, a warming climate is making parts of California more suitable for dengue fever transmission. Nearly half of the state's population now lives in areas where conditions allow for local transmission. As temperatures rise, so does the risk of illness and potential outbreaks.
Researchers identified five immunomodulatory proteins in Borrelia recurrentis that prevent activation of the human complement system, allowing the pathogen to survive in the human body. These Chi proteins also convert plasminogen into active plasmin, giving Borrelia recurrentis a significant advantage in spreading after infection.
Researchers are testing two treatments to help ranchers protect their herds from bovine theileriosis, a deadly disease spread by the invasive Asian longhorned tick. The treatments include a prescription anti-tick vaccine and a slow-release parasiticide, with initial results showing promise in reducing symptoms and mortality rates.
A new dual vaccine against Lassa fever and rabies has been shown to be safe and induce immune responses against both viruses. The vaccine could potentially streamline delivery in settings where access is limited, reducing the need for separate vaccination efforts.
A new study found that AI-powered chatbots can make vaccine-hesitant parents more likely to say they will immunize their children against HPV, but no more than standard written public health materials. Additionally, the effects of the chatbots did not last longer than those of government health materials.
The ACT-CHIK project will conduct a Phase Ib/III clinical trial to evaluate the safety and immunogenicity of a measles-virus-based chikungunya vaccine in four African countries. The project also aims to strengthen Africa's vaccine ecosystem by transferring the vaccine manufacturing process to an African manufacturer.
Researchers have developed an alternative infection model using wax moth larvae to study bacterial pathogens, enabling efficient and ethically acceptable high-throughput testing. The model allows for broad screening of bacterial variants or potential new active compounds in a living organism.
Researchers at UT MD Anderson Cancer Center have made significant advances in understanding cancer biology, developing AI-powered atlas of tertiary lymphoid structures as prognostic biomarkers, and uncovering drivers of resistance to KRAS inhibitors. Additionally, they have discovered a molecular pathway that drives stressed cells to b...
A recent study by University of Gothenburg researchers found that antibiotics for uncomplicated acute sore throats have minimal preventive effect against serious streptococcal infections. Early recognition of warning signs is crucial, and a vaccine is being awaited as a long-term solution.
Dr. Renee Fleeman's research found a bioengineered peptide weakens the defenses of Klebsiella pneumoniae bacteria and destroys it, potentially treating patients with severe infections. The findings show the peptide can kill biofilm-embedded bacteria in animal models.
Scientists at La Jolla Institute for Immunology have discovered that 'cross-reactive' T cells can recognize multiple species of paramyxovirus, including measles and Nipah viruses. This broad protection is essential in combating emerging diseases with unknown viral strains.
A study by Finnish researchers found that MMR vaccines provide sustained protection against measles transmission in Finland, maintaining herd immunity despite high vaccination coverage. The study identified a 'firewall population' of individuals with sufficient immunity to prevent infection and limit viral spread.
A new leishmaniasis vaccine, developed using CRISPR gene-editing technology, is set to begin testing in healthy people for its safety and immune response. The vaccine has shown strong results in mice and has cleared a key FDA hurdle, paving the way for Phase 2 trials aiming to understand its effectiveness.
Researchers have developed an approach to prevent transmission of E. coli K1 bacteria to newborns, reducing the risk of meningitis by up to 80%. The treatment involves an oral vaccination that weakens the bacteria, followed by a harmless probiotic bacterium that competes with the weakened pathogen for food.
Chlamydia notifications decreased in seven European countries, with significant declines among young people. The decline was mainly seen in Sweden, Denmark, England, Finland, Ireland, Norway and the Netherlands, with case numbers dropping by up to 32% in some countries.
A new study published in JAMA Network Open found that approximately 16% of patients with COVID-19 developed long COVID, translating to over 18 million Americans. The study used a novel AI algorithm to identify cases undetected by existing diagnostic systems.
A study reveals that TREM2+ macrophages directly recognize candidalysin, a toxin secreted by Candida albicans, to initiate an immune response. This recognition leads to the activation of key immune cells and the production of pro-inflammatory cytokines, ultimately protecting against fungal infection.
Europe's bacterial STI cases reached record highs in 2024, driven by gonorrhoea and syphilis, with men who have sex with men disproportionately affected. The near doubling of congenital syphilis cases highlights the need for improved antenatal screening protocols to prevent transmission to newborns.
Researchers found that treating woodland trails with woodchips and insecticide significantly reduced the density of blacklegged ticks, a primary vector of Lyme disease. The study demonstrated that both deltamethrin-treated and untreated woodchip interventions can effectively reduce tick populations in recreational contexts.
Researchers used wastewater surveillance to detect drug-resistant Candida auris strains up to five months before patients showed symptoms, opening a new frontier for hospitals. The study found higher detection rates and concentrations of the pathogen in hospital wastewater compared to community-scale treatment plants.
A major new study has found that severe asthma patients are often battling other health conditions, with nearly all suffering from at least one major issue. The study identified three distinct profiles linked to how well asthma is controlled and the treatments needed, offering potential breakthroughs for improving care.
A systematic review by 16 leading researchers at Rutgers University and other institutions highlights recurring problems in studies of infection-associated chronic illnesses, including the failure to prove participants have the relevant pathogen. The authors propose a framework for rigorous study design to confirm diagnoses, choose com...
A study found that adolescents aware of their state's minor consent laws were more likely to seek and receive HIV and other sexually transmitted infections testing. Teens who accurately knew their legal capacity to consent to healthcare services had higher testing rates.
A study found that cefiderocol and levofloxacin improved survival rates and reduced bacterial burdens in mice with severe hemorrhagic pneumonia. However, instances of hemorrhage differed between the two treatments. The results suggest that levofloxacin may be more effective against this infection.
Researchers found a protein called RAB5c that helps white blood cells kill Aspergillus fumigatus, a common airborne fungus. Without this protein, immune cells are disarmed despite attacking at full force. The discovery could lead to new treatments for patients with weakened immune systems.
Researchers develop hemoglobin-based nanoparticles to deliver tigecycline directly to Klebsiella pneumoniae infection sites, improving survival rates and reducing bacterial burden. The novel strategy overcomes dose-limiting toxicity and enhances pharmacokinetics of the antibiotic.
Researchers detected airborne virus, wastewater contamination, and asymptomatic cows on infected dairy farms, suggesting multiple modes of transmission. This finding highlights the need for mitigation strategies to reduce viral spread in herds and humans.
The UK-led OpenBind initiative has released its first publicly available dataset and predictive AI model, accelerating the discovery of new medicines using artificial intelligence. The release showcases high-quality, standardized experimental data and a trained predictive model, enabling researchers worldwide to drive the next generati...
Researchers identified how Mycobacterium abscessus evades treatment and proposed a strategy to overcome resistance, offering a pathway towards more effective treatments. A combination therapy targeting both smooth and rough variants proved more effective than single-phage treatment.
Researchers at La Jolla Institute for Immunology discovered that FluMist can trigger an immune response directly in nasal tissue, training immune cells to recognize and fight influenza virus infection. This response stays in the upper airways and cannot be detected via blood samples.
A new portable device can deliver accurate test results for tuberculosis (TB) in less than half an hour, matching lab accuracy. The MiniDock MTB uses similar technology to COVID-19 tests and detects DNA of mycobacterium tuberculosis, enabling rapid diagnosis and treatment
A recent study found that lower vaccination coverage among infants born to unscreened mothers is associated with a substantial increase in HBV infections. The researchers used simulation modeling to examine the impact of different levels of newborn vaccination coverage and maternal screening on HBV infection rates.